4//SEC Filing
Duncan Gregory Scott 4
Accession 0001415889-24-005666
CIK 0001818844other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 12:40 PM ET
Size
5.4 KB
Accession
0001415889-24-005666
Insider Transaction Report
Form 4
Duncan Gregory Scott
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Stock Option (right to buy)
2024-02-26+138,835→ 138,835 totalExercise: $0.36Exp: 2034-02-26→ Common Stock (138,835 underlying)
Footnotes (1)
- [F1]The stock option will vest 100% on February 26, 2025, one year following the grant date.
Documents
Issuer
Virios Therapeutics, Inc.
CIK 0001818844
Entity typeother
Related Parties
1- filerCIK 0001831127
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 12:40 PM ET
- Size
- 5.4 KB